FDA Bars Ranbaxy Drugs For Manufacturing Violations
The U.S. Food and Drug Administration said it has barred more than 30 drugs manufactured by Ranbaxy Laboratories Ltd. from entering the U.S. after the company failed to address serious manufacturing...To view the full article, register now.
Already a subscriber? Click here to view full article